While much of the public discourse around AI focuses on its theoretical risks or future potential, the technology already has a tangible, measurable impact on healthcare today....
Electronic methods of capture of clinical endpoint data are becoming increasingly dominant, and yet it’s notable that in some respects the industry continues to critique electronic methods in a way paper-based methods are not....
Mass General Brigham, Emory and other providers, including the UW–Madison School of Medicine and Public Health, will assess different AI models from companies like Google, Microsoft and Amazon....
At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and discern ways to overcome sector challenges....
The Wisconsin Alumni Research Foundation (WARF) will commit $15 million over the next three years to extend the University of Wisconsin–Madison’s strength in artificial intelligence research and education by supporting the university’s Research, Innovation and Scholarly Excellence Initiative (RISE) focus on AI....
Artificial Intelligence (AI) is on the cusp of quickly becoming a large component of the healthcare industry (broadly defined), with the emergence of generative AI and sophisticated predictive models making significant inroads across various domains....
Two experts on regulatory and compliance trends weigh in on the FDA's recently issued guidance on decentralized clinical trials....
A review of the FDA's regulation of artificial intelligence (AI) and the potential uses of AI in medical product development, clinical research, and clinical care....
The pharmaceutical industry has begun leveraging artificial intelligence (AI) to streamline numerous aspects of drug development from identification of novel drug targets to clinical trial design....
University of Wisconsin–Madison Chancellor Jennifer L. Mnookin announced that the newest area of focus for the Wisconsin Research, Innovation and Scholarly Excellence (RISE) Initiative, called RISE-THRIVE, will be aimed at advancing health and improving lives....
